Download in electronic PDF format for $65
Abstract: Autism incorporates most of the characteristics of a metabolic disorder. In this discussion, the author focuses on biochemical markers, causes of autism and treatments.
Related Keywords:
autism, autistic, autistic children
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Autism in Children
Cave Stephanie
|
Jan/Feb 2001
Pg. 18-19
|
Topical Secretin for the Treatment of Autism
King Erin, Toney Steve
|
Nov/Dec 2001
Pg. 436-437
|
Unlocking Autism: Is Compounding the Key?
Vail Jane
|
Nov/Dec 2005
Pg. 413-420
|
PostScription: Compounding Pharmacies and the Successful Treatment of Autism
Neurander James A
|
Nov/Dec 2005
Pg. 487-488
|
Compounding Naltrexone for the Treatment of Autism
Wynn Tom, Brunetti Sarah
|
Jul/Aug 2009
Pg. 296-299
|
Oral Rehydration Salts (World Health Organization/United Nations Children's Fund)
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 390
|
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
|
May/Jun 2007
Pg. 220-225
|
Compounding for Pediatric Patients: Case Reports and Formulations
Mixon William, Angelle Patricea, Yoch Douglas
|
Jan/Feb 2009
Pg. 6-12
|
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children
Nahata Milap C
|
May/Jun 2016
Pg. 247-249
|
Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children
Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
|
May/Jun 2016
Pg. 257-261
|
